ClinicalTrials.gg
CompletedNCT06353516Updated May 14, 2026

The Effect of Intravenous Versus Volatile Anesthesia on Postoperative Cognitive Dysfunction in Elderly Patients

An interventional study of Propofol and Sevoflurane in Postoperative Cognitive Dysfunction, sponsored by Chung-Ang University Gwangmyeong Hospital. Completed at 1 site in South Korea. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-05-14.

Sponsored by Chung-Ang University Gwangmyeong Hospital · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
154
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to compare the permeability of blood-brain barrier between the intravenous anesthesia group and the inhalation gas anesthesia group in the elderly patients undergoing surgery. The main questions it aims to answer are:

  • [Is the permeability of blood-brain barrier between the intravenous anesthesia group and the inhalation gas anesthesia group in the elderly patients different?]
  • [Is the incidence of postoperative cognitive dysfunction between the intravenous anesthesia group and the inhalation gas anesthesia group different?] Participants will be anesthetized with different categories of anesthetics.

    • Intravenous anesthetics
    • Inhalation gas anesthetics
Read the detailed description

This clinical trial targets patients aged 60 years or older with American Society of Anesthesiologists physical status (ASA) 1 to 3 who undergo surgery under general anesthesia at our hospital. Before entering the operating room, patients are randomly assigned to the intravenous anesthesia group and the inhalation gas anesthesia group. The intravenous anesthesia group uses propofol for anesthesia, and the inhalation gas anesthesia group uses sevoflurane. A 3 mL blood sample is collected four times: before surgery, at the end of surgery, 4 hours after surgery, and 1st day after surgery. All blood samples will be immediately transferred to the department of Laboratory medicine and stored at -80 degree. Pre-scheduled tests to determine the brain-blood barrier permeability and inflammatory cytokines will be conducted after the recruitment of all samples. In addition, for patients scheduled to be transferred to the intensive care unit (ICU) after surgery among the study subjects, a 3 mL of cerebrospinal fluid sample is collected two times: before surgery, and at the end of surgery. The same preservation protocol will be applied to the cerebrospinal fluid samples. All study subjects will be monitored for postoperative delirium daily for up to 7 days after surgery or until discharge. Cognitive function is assessed using telephone version of the Montreal Cognitive Assessment (T-MOCA) before surgery and 3 months after surgery.

02

Conditions studied

  • Postoperative Cognitive Dysfunction

Keywords

  • total intravenous anesthesia
  • inhaled gas anesthesia
  • blood-brain barrier permeability
  • neuroinflammation
  • delirium
  • postoperative cognitive dysfunction
03

In context

Postoperative Cognitive Complications

261 studies on the registry are indexed under Postoperative Cognitive Complications; 56 are open to participants now.

This study's enrollment of 154 is above the median of 106 across 146 interventional studies indexed under Postoperative Cognitive Complications.

Browse Postoperative Cognitive Complications studies →

Lead sponsor

Chung-Ang University Gwangmyeong Hospital is the lead sponsor of 5 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age equal to or older than 60
  • (ASA) grade I to III
  • general anesthesia longer than 2 hours

Exclusion criteria

Exclusion Criteria:

  • history of dementia
  • history of schizophrenia, epilepsy, or Parkinson's disease
  • history of stroke or craniectomy
  • patient denial
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
154 participants (actual)

Study arms

  • Active comparator
    Intravenous Anesthesia

    The anesthesia is maintained with intravenous anesthetics

    Drug: Propofol

  • Sham comparator
    Inhaled Gas Anesthesia

    The anesthesia is maintained with inhaled gas anesthetics

    Drug: Sevoflurane

Interventions

  • delivered via intravenous route

  • DrugSevoflurane

    delivered via inhalation route

06

What researchers measure

Primary outcomes

  1. Concentration of serum S100B levels

    Levels of S100B will be obtained from venous blood samples collected before surgery, at the end of surgery, 4 hours after surgery, and 1st day after surgery.

    Time frame: before surgery, at the end of surgery, 4 hours after surgery, 1st day after surgery

Secondary outcomes

  1. Incidence of Delirium

    Investigators will investigate the occurrence of Delirium using CAM or CAM-ICU (in case of ICU admission). during 7 postoperative days or until discharge if the postoperative hospital stay is shorter than 7 days.

    Time frame: during 7 postoperative days or until discharge if the postoperative hospital stay is shorter than 7 days

  2. Incidence of Postoperative Cognitive Dysfunction

    The T-MOCA is a validated cognitive function test. The investigators will investigate changes in T-MOCA between baseline and 3 months after surgery.

    Time frame: before surgery, 3 months after surgery

  3. Concentration of serum albumin

    Levels of albumin will be obtained from venous blood samples collected before surgery, at the end of surgery, 4 hours after surgery, and 1st day after surgery.

    Time frame: before surgery, at the end of surgery, 4 hours after surgery, 1st day after surgery

  4. Concentration of serum CRP

    Levels of CRP will be obtained from venous blood samples collected before surgery, at the end of surgery, 4 hours after surgery, and 1st day after surgery.

    Time frame: before surgery, at the end of surgery, 4 hours after surgery, 1st day after surgery

  5. Concentration of serum IL6 levels

    Levels of IL6 will be obtained from venous blood samples collected before surgery, at the end of surgery, 4 hours after surgery, and 1st day after surgery.

    Time frame: before surgery, at the end of surgery, 4 hours after surgery, 1st day after surgery

  6. Concentration of serum TNFα levels

    Levels of TNFα will be obtained from venous blood samples collected before surgery, at the end of surgery, 4 hours after surgery, and 1st day after surgery.

    Time frame: before surgery, at the end of surgery, 4 hours after surgery, 1st day after surgery

  7. Concentration of cerebrospinal fluid (CSF) albumin

    (in case of schedulled ICU admission) Levels of albumin will be obtained from CSF samples collected before surgery, at the end of surgery in case of schedulled ICU admission.

    Time frame: Within 24 hour before surgery, at the end of surgery

07

Study locations

1 site
  • Chung-Ang University Gwangmyeong Hospital
    Gwangmyeong, Gyeonggi-do 14353, South Korea
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data that underlies the results of this study will be made available upon reasonable request, after deidentification (text, tables, figures, and appendices).

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Beginning 3 months and ending 5 years following article publication

Access criteria: Data will be available to researchers who provide a methodologically sound proposal to the corresponding author of the article. To gain access, data requestors will need to sign a data access agreement.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2024 to primary completion in Oct 2024, 6 months.

Of 63 non-industry interventional studies with no phase under Postoperative Cognitive Complications, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 33. This study's 6 months is below that.

Counting every sponsor, half of 63 studies reached it within 16 months; a quarter within 8 and three quarters within 33.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 13, 2024
First posted
Apr 9, 2024
StartActual
Apr 10, 2024
Primary completionActual
Oct 30, 2024
CompletionActual
Dec 31, 2024
Last update
May 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06353516
Lead sponsor
Chung-Ang University Gwangmyeong Hospital
Collaborators
National Research Foundation of Korea
Responsible party
Eun Jung Oh (Assistant Professor, Chung-Ang University Gwangmyeong Hospital) — Principal investigator
First posted
Apr 9, 2024
Start date
Apr 10, 2024
Primary completion
Oct 30, 2024
Completion
Dec 31, 2024
Last update
May 14, 2026

Study contacts

Eun Jung Oh, M.D., Ph.D.
study director · Chung-Ang University Gwangmyeong Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Propofol

Start the discussion